From: Multi-level model for the investigation of oncoantigen-driven vaccination effect
Cell line
ErbB2 (%)
TLR2 (%)
E
52.7 ± 4.2
8 ± 1
P1
51.9 ± 12.7
21 ± 3
P2
45.5 ± 10.5
24.5 ± 5.3
P3
41.2 ± 10.4
27.1 ± 3.8